CCN2 and non-small cell lung carcinoma: An application of tested compounds (5-dAzaC and TSA) could be of benefit in NSCLC, at least for two reasons: not only they increased the amount of CTGF transcripts and protein in NSCLC cell lines, but they also contributed to the reduction in cell proliferation.